699.10 Importance of the medial amygdala to the
neurogenic hypertension in Schlager mice.
K.L. Jackson, T-P.
Nguyen-Huu, K. Palma-Rigo, P.J. Davern and G.A. Head.
BakerIDI Heart and Diabetes Inst., Melbourne and Monash
Univ., Australia.
B254
699.11 Bradykinin B2 receptor contributes to
exaggerated muscle mechanoreflex in rats with femoral artery
occlusion.
J. Lu, J. Xing and J. Li. Penn State Col. of Med.
B255
699.12 TRPA1 mediates amplified sympathetic
responsiveness in rats with femoral artery occlusion.
J. Xing,
J. Lu and J. Li. Penn State Col. of Med.
B256
699.13 Interactions between carotid body denervation
and renal nerve denervation in lowering arterial blood pressure
in the adult spontaneously hypertensive rat.
F.D. McBryde,
A.P.L. Abdala, E.B. Hendy, Z. Engelman, M. Fudim and
J.F.R. Paton. Univ. of Bristol and Cibiem Inc., New York.
B257
699.14 Exercise training normalizes subfornical
organ-mediated sympathoexcitation in chronic heart failure.
T.L. Llewellyn, H. Zheng, N.M. Sharma and K.P. Patel. Univ.
of Nebraska Med. Ctr.
B258
699.15 Tiron, a superoxide scavenger, suppresses
fictive locomotion-evoked sympathoexcitation in rats with heart
failure.
S. Koba, Y. Inoue, I. Hisatome and T. Watanabe. Tottori
Univ. Fac. of Med. and Grad. Sch. of Med. Sci., Japan.
B259
699.16 Neuroplasticity in the nucleus tractus solitarius
precedes development of functional changes in autonomic
regulation of arterial pressure in obese Zucker rats.
G.J. Fu,
D.A. Huber and A.M. Schreihofer. Univ. of North Texas Hlth.
Sci. Ctr.
B260
699.17 Intermittent hypoxia in vitro reduces TRPC4
and neuropeptide expression in 4B cells.
T.P. Nedungadi, M.
Bachelor and J.T. Cunningham. Univ. of North Texas Hlth.
Sci. Ctr.
PHYSIOLOGY SUNDAY
211
S
U
N
B261
699.18 Angiotensin II contributes to microglial cell
activation in the PVN of hypertensive rats.
V.C. Biancardi and
J.E. Stern. Georgia Hlth. Sci. Univ.
B262
699.19 Tyrosine hydroxylase expression is elevated
in the intermediolateral cell column of upper, but not lower
thoracic spinal segments of rats with ischemic heart failure.
K.E. Scrogin, A. Samarel and Y. Koshman. Loyola Univ.
Chicago, Stritch Sch. of Med.
B263
699.20 Median preoptic nucleus neurons
activated following chronic intermittent hypoxia project to
the paraventricular nucleus.
K.E. Faulk, J. Little and T.
Cunningham. Univ. of North Texas Hlth. Sci. Ctr.
700. CEREBRAL CIRCULATION I
Poster
s
un
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B264
700.1
Cerebroprotective effects of selective head
cooling during epileptic seizures.
H. Parfenova, M. Harsono,
J. Liu, S. Basuroy, E.J. Jolly, A. de Jongh Curry, D. Zhuang,
C.W. Leffler and M. Pourcyrous. Univ. of Tennessee, Memphis
and Univ. of Memphis.
B265
700.2
Cerebral ischemia and reperfusion increases
the heterogeneity of local oxygen supply/consumption balance.
H.R. Weiss, J. Grayson, H. Shah, S. Barsoum, X. Liu and
O.Z. Chi. Robert Wood Johnson Med. Sch.
B266
700.3
Hypertension-induced endothelial dysfunction
and posterior communicating artery remodeling.
P.W. Pires
and A.M. Dorrance. Michigan State Univ.
B267
700.4
Sympathetic perivascular nerves contribute to
hypoxic transformation of smooth muscle phenotype in ovine
cerebral arteries.
O.O. Adeoye, J. Silpanisong, J.M. Williams
and W.J. Pearce. Loma Linda Univ.
B268
700.5
Remodeling and impaired dilation in middle
cerebral arteries from deoxycorticosterone acetate-salt rats.
N.
Matin, P.W. Pires, H. Garver and A.M. Dorrance. Michigan
State Univ.
B269
700.6
GPER1 agonist improves cerebral
microvascular function after hypoxia/reoxygenation injury in
male and female rats.
T. Murata, H.H. Dietrich, T. Horiuchi, K.
Hongo and R.G. Dacey, Jr. Shinshu Univ. Sch. of Med., Japan
and Washington Univ. Sch. of Med.
B270
700.7
The influence of inlet boundary conditions
upon hemodynamic analysis of human cerebral aneurysms
with computational fluid dynamics technique.
S. Fukuda, Y.
Shimogonya, T. Tsukahara, Y. Imoto, S. Morikawa and M.
Fukuda. Kyoto Med. Ctr., Univ. of Hyogo and Kyoto Univ.
B271
700.8
Signal transduction in cerebral arteries after
subarachnoid hemorrhage—a phosphoproteomic approach.
G.K. Povlsen, B. Parker, M.R. Larsen and L. Edvinsson.
Glostrup Hosp., Denmark, Univ. of Sydney and Univ. of
Southern Denmark.
B272
700.9
Increased production of the arachidonic acid
metabolite 20-HETE contributes to hypertension-induced
cerebrovascular alterations.
P. Toth, A. Csiszar, D. Sosnowska,
Z. Tucsek, P. Cseplo, Z. Springo, S. Tarantini, W.E. Sonntag,
Z. Ungvari and A. Koller. Reynolds Oklahoma Ctr. on Aging,
Univ. of Oklahoma, Oklahoma City, Univ. of Pecs, Hungary and
New York Med. Col.
B273
700.10 Acute effects of conjugate equine estrogen
on postischemic pial arteriole vasodilation and microvascular
cyclooxygenase expression in young and aged female rats.
E. Zeynalov, L. Ma, N. Rezvani and M.T. Littleton-Kearney.
Uniformed Svcs. Univ. of Hlth. Sci.
B274
700.11 Biotelemetry of intracranial pressure in freely
moving rats: a detailed description of surgical implantation
for chronic studies.
D. McLeod, L. Murtha, J. Burke and K.
Pitsillides. Univ. of Newcastle and Hunter Med. Res. Inst.,
Australia and Transonic EndoGear Inc., Davis.
B275
700.12 Oscillatory pulse pressure changes endothelial
sensitivity to shear stress and myogenic tone in isolated mouse
cerebral arteries.
V. Bolduc, O. Colinas, F. Lesage, W.C. Cole
and E. Thorin. Montreal Heart Inst., Univ. of Calgary and Univ.
of Montreal.
701. DIABETES AND INSULIN RESISTANCE I
Poster
s
un
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B276
701.1
Impact of physical activity on age-related
insulin resistance: the contribution of post-transcriptional gene
silencing.
T. Bunprajun, V. Chatsudthipong, B.K. Pedersen
and C.J. Green. Mahidol Univ., Thailand and Rigshosp., Univ.
of Copenhagen.
B277
701.2
Insulin resistance due to nutrient excess:
mechanisms of AMPK downregulation.
A.K. Saha, T.W. Balon,
K.A. Coughlan and N.B. Ruderman. Boston Univ. Med. Ctr.
B278
701.3
The lipid peroxidation end-product and oxidant
4-hydroxynonenal causes insulin resistance in rat slow-twitch
skeletal muscle in vitro.
E.J. Henriksen, M. Prasannarong,
F.R. Santos and F.J. Giovannini. Univ. of Arizona.
B279
701.4
Valproic acid does not affect decreased insulin
secretion in WFS1-deficient pancreatic islets.
S. Koks, M.
Ivask, A. Hugill, A. Terasmaa, M. Plaas and E. Vasar. Univ. of
Tartu, Estonia and Mammalian Genet. Unit, Harwell, U.K.
B280
701.5
Expression and activity of neutral
sphingomyelinase in the kidney of diabetic rats.
M. Bautista,
L. del Valle-Mondragón, A. Cano-Mártinez, A. Mercado, M.
Franco and E. Zarate-Calleja. Ignacio Chávez Natl. Heart
Inst., Mexico City.
B281
701.6
Carboxylesterase 1 gene duplication and
mRNA expression in adipose tissue are linked to obesity
and metabolic function.
M. Friedrichsen, P. Poulsen, J.
Wojtaszewski, P.R. Hansen, A. Vaag and H.B. Rasmussen.
Univ. of Copenhagen, Rigshospitalet, Copenhagen, Novo
Nordisk A/S, Bagsværd, Copenhagen Univ. Hosp., Gentofte
and Roskilde, Denmark.
B282
701.7
The role of STIM1 and store operated calcium
entry in glucose-induced insulin secretion.
L. Zou and J.C.
Chatham. Univ. of Alabama at Birmingham.
B283
701.8
Combined effects of streptozotocin and
doxorubicin on cardiac function in rats.
S.E. Greufe, N.M.
Gibson, D.S. Hydock, C.M. Schneider and R. Hayward. Univ.
of Northern Colorado.
B284
701.9
Diabetic mouse hearts: a good predictor for
the human population?
T.L. Croston, A.A. Holden, K. Tveter,
S.E. Lewis, D. Thapa, D.L. Shepherd, C.E. Nichols, R.
Jagannathan and J.M. Hollander. West Virginia Univ.
SUNDAY PHYSIOLOGY
212
B285
701.10 Translational regulation of the mitochondrial
genome following redistribution of mitochondrial microRNA in
the diabetic heart.
R. Jagannathan, D. Thapa, W.A. Baseler,
D.L. Shepherd, T.L. Croston, C.E. Nichols, S.E. Lewis and
J.M. Hollander. West Virginia Univ.
702. DIABETIC RENAL DISEASE
Poster
s
un
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B286
702.1
Chymase protein expressed in principal cells
of inner medullary collecting ducts in diabetic kidney disease.
K.A. Wood, S.M. Ford, Jr., P.M. Berner, N. Naqvi, A. Husain
and L.M. Harrison-Bernard. LSU Hlth. Sci. Ctr., Loyola Univ.
New Orleans and Emory Univ.
B287
702.2
Analysis of renal ganglioside GM3 distribution
in rat models of type 1 and type 2 diabetes. J. Bozic, A. Novak,
T. Ticinovic Kurir, N. Rezic-Muzinic, V. Cikes-Culic, L. Puljak, L.
Ferhatovic, A. Markotic and Z. Valic. Univ. of Split Sch. of Med.
and Univ. Hosp. Split, Croatia.
B288
702.3
Changes in levels of mitochondrial nitric oxide
in diabetic rats treated with Eryngium carlinae.
R. Noriega-
Cisneros, M. Arellano-Plaza, E. Esquivel-Gutiérrez, C.
Cortés-Rojo, S. Manzo-Avalos, R. Salgado-Garciglia and
A. Saavedra-Molina. Univ. Michoacana de San Nicolás de
Hidalgo, Mexico.
B289
702.4
Dot1a functions as a novel renoprotective
factor by repressing endothelin 1 in diabetic mice.
L. Chen,
H. Wu, Q. Zhou and W. Zhang. Univ. of Texas Med. Sch. at
Houston, Central South Univ., China.
B290
702.5
Meprin deficient mice have a more severe form
of diabetic nephropathy.
S. Conley, J. Han, S. Hurley and E.M.
Ongeri. North Carolina A&T State Univ.
B291
702.6
RAS blockade inhibits Bcl-2 modifying factor
expression and prevents hypertension and tubular apoptosis
in diabetic Akita mouse kidneys.
H. Maachi, C-S. Lo, S. Abdo,
I. Chenier, S-L. Zhang and J.S.D. Chan. CHUM-Hotel Dieu
Hosp., Montreal.
B292
702.7
Population differences in uropathic bacteria in
diabetic and meprin-deficient mouse models.
J. Whitaker, S.
Conley, S.H. Harrison, E. Ongeri, S.L. Hurley and J. Han.
North Carolina A&T State Univ.
B293
702.8
Oryeongsan improves diabetes-associated
renal proliferation and fibrosis in cultured rat mesangial cells.
J.J. Yoon, Y.J. Lee, S.M. Lee, Y.P. Lee, D.H. Kim, B. Lee, D.G.
Kang and H.S. Lee. Wonkwang Univ., South Korea.
B294
702.9
H
2
S therapy improves MMP-9 and NMDA
receptor-mediated diabetic renovascular remodeling.
S.
Kundu, S. Pushpakumar, S.C. Tyagi and U. Sen. Univ. of
Louisville.
B295
702.10 Chronic ETA receptor blockade prevents the
progression of renal injury in diabetic Dahl salt-sensitive rats.
D.
Spires, T. Slaughter, L. Taylor, N. Kojima and J.M. Williams.
Tougaloo Col. and Univ. of Mississippi Med. Ctr.
B296
702.11 Prolonged high glucose treatment increased
STIM1/Orai1 protein expression and enhanced store-operated
Ca
2+
entry in human glomerular mesangial cells.
S. Chaudhari,
Y. Wang, M. Ding, Y. Ding, J. Yuan and R. Ma. Univ. of North
Texas Hlth. Sci. Ctr.
B297
702.12 ER
a66 contributes to early diabetic renal
disease in mice.
D.L. Irsik, R.W. Fallet, E. Adun, E. Chavez,
H.L. Brooks, P.K. Carmines and P.H. Lane. Univ. of Nebraska
Med. Ctr., Univ. of Arizona and Univ. of Oklahoma Hlth. Sci. Ctr.
B298
702.13 Effect of diet on the progression of diabetic
nephropathy in db/db mice.
S.S. Kandlikar, K.M. Joly, T.R.
Horn, C.G. Glascock and C.F. Plato. Plato BioPharma Inc.,
Westminster, CO.
B299
702.14 Dose-dependent effects of losartan and salt-
sensitivity of diabetic nephropathy in ZSF1 rats.
C.F. Plato,
S.L. Silva, K.M. Joly and T.R. Horn. Plato BioPharma Inc.,
Westminster, CO.
703. HORMONE AND AUTOCOID EFFECTS ON THE
KIDNEY
Poster
s
un
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B300
703.1
PDGF receptor antagonism prevents the
increase in urinary angiotensin II excretion in Cyp1a1-Ren2
transgenic rats with angiotensin II-dependent malignant
hypertension.
C.J. Milani, C.G. Howard, D.M. Seth, P.D. Davis
and K.D. Mitchell. Tulane Univ.
B301
703.2
Chronic high fructose intake impairs renal
calcitriol metabolism.
V. Douard, C. Patel, Y. Sabbagh, J. Lee
and R.P. Ferraris. UMDNJ, Newark and Sanofi-Genzyme,
Framingham, MA.
B302
703.3
Co-immunolocalizing proteins involved in
fructose metabolism and calcitriol regulation in the rat kidney.
M. Dorcinvil, V. Douard, L. Fritzky, D. Lagunoff, Y. Sabbagh
and R.P. Ferraris. UMDNJ, Newark and Sanofi-Genzyme,
Framingham, MA.
B303
703.4
Interactions of hypoxia inducible factor-1
a and
peroxisome proliferator-activated receptor
a in the protection
against ischemia/reperfusion injury in the rat kidney.
M. Dallatu
and A. Oyekan. Texas Southern Univ.
B304
703.5
Role of mTOR signaling in compensatory
hypertrophy following uninephrectomy in the rat.
C. Myung and
A. Oyekan. Texas Southern Univ.
B305
703.6
Human mesangial cells treated with
lipopolysaccharide mimicking human sepsis are able to
produce catecholamines.
D.C.G.P. Magalhaes, D.Y. Arita, D.S.
Aragão, W.S. Almeida and D.E. Casarini. Fed. Univ. of São
Paulo.
B306
703.7
The anandamide cyclooxygenase-2
metabolite, prostamide E2, as a novel diuretic and natriuretic
lipid in the mouse renal medulla.
J.K. Ritter, C. Li, M. Xia, K.M.
Boini, A.H. Lichtman and P-L. Li. Virginia Commonwealth
Univ.
PHYSIOLOGY SUNDAY
213
S
U
N
704. OXIDATIVE STRESS I
Poster
s
un
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B307
704.1
Low molecular weight fucoidan against renal
ischemia-reperfusion injury via inhibition of the MAPK signaling
pathway.
H. Zhou, J. Chen and B. Yang. Peking Univ.
B308
704.2
Suppression of inflammatory cytokines in the
kidney during chronic high salt intake in wild type and e-NOS
knockout mice.
P. Singh, A. Castillo and D.S.A. Majid. Tulane
Med. Sch.
B309
704.3
b-Caryophyllene ameliorates cisplatin-induced
nephrotoxicity in a cannabinoid 2 receptor-dependent manner.
P. Pacher, B. Horvath, P. Mukhopadhyay, D. Wink and J.
Gertsch. NIAAA, NIH, Rockville, NCI, NIH and Univ. of Bern.
B310
704.4
Evaluation of the role of the NAD(P)H oxidase
subunit p67
phox
in the regulation of medullary blood flow in
Dahl S rats.
L.C. Evans, R. Ryan, T. Kurth, M. Skelton and A.
Cowley, Jr. Med. Col. of Wisconsin.
B311
704.5
NADPH oxidase and ETA receptors mediate
glomerular reactive oxygen species production in sickle cell
nephropathy.
B. Heimlich , P.M. O’Connor, S.E. Meiler and
D.M. Pollock. Georgia Hlth. Sci. Univ.
B312
704.6
Inhibition of hyperhomocysteinemia-induced
inflammasome activation and glomerular sclerosis by NLRP3
gene deletion.
K.M. Boini, M. Xia, J.M. Abais, Y. Zhang, T.W.
Gehr and P-L. Li. Virginia Commonwealth Univ.
B313
704.7
Thioredoxin-interacting protein mediates
Hcys-induced NLRP3 inflammasome activation in mouse
podocytes.
J. Abais, K.M. Boini, M. Xia and P-L. Li. Virginia
Commonwealth Univ.
B314
704.8
Calcineurin
b regulates NADPH oxidases in
kidney hypertrophy.
C.R. Williams and J.L. Gooch. Emory
Univ. Sch. of Med. and Atlanta VA Med. Ctr.
B315
704.9
COX-2 induction is ROS dependent in rats
during 3 days unilateral ureteral obstruction.
M. Østergaard,
L. Nilsson, J. Frøkiær and R. Nørregaard. Aarhus Univ.,
Denmark.
B316
704.10 Nrf2 mediates the antioxidant effect of DJ-1
in the kidney.
S. Cuevas, Y. Yang, L. Asico, C.S. Escano, I.
Armando and P.A. Jose. Univ. of Maryland Sch. of Med.
B317
704.11 Inhibition of nitric oxide generation enhances
superoxide production in cultured HK2 and M1 cells.
M.T.
Islam, A.K. Maiti, R. Sato and D.S.A. Majid. Tulane Univ. Hlth.
Sci. Ctr.
B318
704.12 Nrf2 antioxidant pathway activation attenuates
renal ischemia/reperfusion-induced alterations in biomarkers.
T.L. Richards, K.K. Ida, T.R. Horn, S.S. Kandlikar and C.F.
Plato. Plato BioPharma Inc., Westminster, CO.
B319
704.13 C3H mice are resistant to hypertensive
renovascular remodeling due to decreased mitochondrial
oxidative stress.
S. Pushpakumar, S. Kundu, S. Givvimani,
S.C. Tyagi and U. Sen. Univ. of Louisville.
705. RENAL PATHOLOGY, TOXICOLOGY AND
CYSTIC DISEASES
Poster
s
un
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B320
Dostları ilə paylaş: |